Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond

References

• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017;46:562–41.
   PubMed Web of Science ®Google Scholar
• Khan I, Bai Y, Zha L, Ullah N, Ullah H, Shah SRH, Sun H, Zhang C. Mechanism of the gut microbiota colonization resistance and enteric pathogen infection. Front Cell Infect Microbiol. 2021;11:716299.
   PubMed Web of Science ®Google Scholar
• Heiss CN, Olofsson LE. Gut microbiota-dependent modulation of energy metabolism. J Innate Immun. 2018;10:163–171.
   PubMed Web of Science ®Google Scholar
• Patterson E, Cryan JF, Fitzgerald GF, Ross RP, Dinan TG, Stanton C. Gut microbiota, the pharmabiotics they produce and host health. Proc Nutr Soc. 2014;73:477–489.
   PubMed Web of Science ®Google Scholar
• Cryan JF, O’ Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99:1877–2013.
   PubMed Web of Science ®Google Scholar
• Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019;12:843–850.
   PubMed Web of Science ®Google Scholar
• De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms. 2021;9:353.
   PubMed Web of Science ®Google Scholar
• Baranowski JR, Claud EC. Necrotizing enterocolitis and the preterm infant microbiome In: Internet. In: Guandalini S Indrio F, editors. Probiotics and Child Gastrointestinal Health. Cham: Springer International Publishing;2019. [cited 2022 May 16]. 25–36.Available from. https://link.springer.com/10.1007/5584_2018_313
   Google Scholar
• Duchon J, Barbian ME, Denning PW. Necrotizing enterocolitis. Clin Perinatol. 2021;48:229–250.
   PubMed Web of Science ®Google Scholar
• Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216:20–40.
   PubMed Web of Science ®Google Scholar
• Pascal M, Perez-Gordo M, Caballero T, Escribese MM, Lopez Longo MN, Luengo O, Manso L, Matheu V, Seoane E, Zamorano M, et al. Microbiome and allergic diseases. Front Immunol. 2018;9:1584.
   PubMed Web of Science ®Google Scholar
• Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, Kerr C, Hourihane J, Murray D, Fuligni F, et al. Diversity of bifidobacteria within the infant gut microbiota. PloS One. 2012;7:e36957.
   PubMed Web of Science ®Google Scholar
• Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol. 2016;7:1204.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yu Z, Zhao J, Zhang H, Zhai Q, Chen W. Colonization and probiotic function of Bifidobacterium longum. J Funct Foods. 2019;53:157–165.
   Web of Science ®Google Scholar
• FAO/WHO. Food and Agriculture Organization and World Health Organization Expert Consultation. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. [Internet]. Available from: http://www.fao.org/tempref/docrep/fao/meeting/009/y6398e.pdf
   Google Scholar
• Finlay BB. CIFAR Humans, the Microbiome. Are noncommunicable diseases communicable? Science. 2020;367:250–251.
   PubMedGoogle Scholar
• Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491–502.
   PubMed Web of Science ®Google Scholar
• Kelly WJ, Cookson AL, Altermann E, Lambie SC, Perry R, Teh KH, Otter DE, Shapiro N, Woyke T, Leahy SC. Genomic analysis of three Bifidobacterium species isolated from the calf gastrointestinal tract. Sci Rep. 2016;6:30768.
   PubMed Web of Science ®Google Scholar
• Mattarelli P, Bonaparte C, Pot B, Biavati B. Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. Suis Comb Nov Int J Syst Evol Microbiol. 2008;58:767–772.
   PubMed Web of Science ®Google Scholar
• Underwood MA, German JB, Lebrilla CB, Mills DA. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr Res. 2015;77:229–235.
   PubMed Web of Science ®Google Scholar
• Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A. 2008;105:18964–18969.
   PubMed Web of Science ®Google Scholar
• Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao J-Z, Abe F, Osawa R. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016;16:90.
   PubMed Web of Science ®Google Scholar
• Odamaki T, Bottacini F, Kato K, Mitsuyama E, Yoshida K, Horigome A, Xiao J-Z, van Sinderen D. Genomic diversity and distribution of Bifidobacterium longum subsp. longum across the human lifespan. Sci Rep. 2018;8:85.
   PubMed Web of Science ®Google Scholar
• Chaplin AV, Brzhozovskii AG, Parfenova TV, Kafarskaia LI, Volodin NN, Shkoporov AN, Ilina EN, Efimov BA. Species diversity of bifidobacteria in the intestinal microbiota studied using MALDI-TOF Mass-Spectrometry. Vestn Ross Akad Med Nauk. 2015;435–440.
   PubMedGoogle Scholar
• Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, Matsumoto K, Tanaka R. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol. 2004;70:167–173.
   PubMed Web of Science ®Google Scholar
• Turroni F, Foroni E, Pizzetti P, Giubellini V, Ribbera A, Merusi P, Cagnasso P, Bizzarri B, De’angelis GL, Shanahan F, et al. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microbiol. 2009;75:1534–1545.
   PubMed Web of Science ®Google Scholar
• Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D, Satokari R, Franceschi C, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PloS One. 2010;5:e10667.
   PubMed Web of Science ®Google Scholar
• Claesson MJ, Cusack S, O’ Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4586–4591.
   PubMed Web of Science ®Google Scholar
• Ragonnaud E, Biragyn A. Gut microbiota as the key controllers of “healthy” aging of elderly people. Immun Ageing. 2021;18:2.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Yang C, Yu L, Tian F, Wu Y, Zhao J, Zhang H, Yang R, Chen W, Hill C, et al. Human gut-derived B. longum subsp. longum strains protect against aging in a d-galactose-induced aging mouse model. Microbiome. 2021;9:180.
   PubMed Web of Science ®Google Scholar
• Arboleya S, Bottacini F, O’ Connell-Motherway M, Ryan CA, Ross RP, van Sinderen D, Stanton C. Gene-trait matching across the Bifidobacterium longum pan-genome reveals considerable diversity in carbohydrate catabolism among human infant strains. BMC Genomics. 2018;19:33.
   PubMed Web of Science ®Google Scholar
• Garrido D, Ruiz-Moyano S, Kirmiz N, Davis JC, Totten SM, Lemay DG, Ugalde JA, German JB, Lebrilla CB, Mills DA. A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. Longum SC596 Sci Rep. 2016;6:35045.
   PubMed Web of Science ®Google Scholar
• Kelly SM, Munoz-Munoz J, van Sinderen D. Plant glycan metabolism by bifidobacteria. Front Microbiol. 2021;12:609418.
   PubMed Web of Science ®Google Scholar
• Matijašić B B, Obermajer T, Lipoglavšek L, Sernel T, Locatelli I, Kos M, Šmid A, Rogelj I. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: a randomized double-blind, placebo-controlled trial. J Dairy Sci. 2016;99:5008–5021.
   PubMed Web of Science ®Google Scholar
• Costa GN, Marcelino-Guimarães FC, Vilas-Bôas GT, Matsuo T, Miglioranza LHS. Potential fate of ingested Lactobacillus plantarum and its occurrence in human feces. Appl Environ Microbiol. 2014;80:1013–1019.
   PubMed Web of Science ®Google Scholar
• Oki K, Akiyama T, Matsuda K, Gawad A, Makino H, Ishikawa E, Oishi K, Kushiro A, Fujimoto J. Long-term colonization exceeding six years from early infancy of Bifidobacterium longum subsp. longum in human gut. BMC Microbiol. 2018;18:209.
   PubMed Web of Science ®Google Scholar
• Milani C, Lugli GA, Duranti S, Turroni F, Bottacini F, Mangifesta M, Sanchez B, Viappiani A, Mancabelli L, Taminiau B, et al. Genomic encyclopedia of type strains of the genus Bifidobacterium. Appl Environ Microbiol. 2014;80:6290–6302.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543–547.
   PubMed Web of Science ®Google Scholar
• Chichlowski M, Shah N, Wampler JL, Wu SS, Vanderhoof JA. Bifidobacterium longum subspecies infantis (B. infantis) in pediatric nutrition: current state of knowledge. Nutrients. 2020;12:1581.
   PubMed Web of Science ®Google Scholar
• Z-T Y, Chen C, Kling DE, Liu B, McCoy JM, Merighi M, Heidtman M, Newburg DS. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology. 2013;23:169–177.
   PubMed Web of Science ®Google Scholar
• Henrick BM, Hutton AA, Palumbo MC, Casaburi G, Mitchell RD, Underwood MA, Smilowitz JT, Frese SA. Elevated fecal pH Indicates a profound change in the breastfed infant gut microbiome due to reduction of Bifidobacterium over the past century. mSphere. 2018;3:18–e00041.
   Web of Science ®Google Scholar
• Wu W, Sun M, Chen F, Cao AT, Liu H, Zhao Y, Huang X, Xiao Y, Yao S, Zhao Q, et al. Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol. 2017;10:946–956.
   PubMed Web of Science ®Google Scholar
• Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr. 2004;91:915–923.
   PubMed Web of Science ®Google Scholar
• Peng L, Li Z-R, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139:1619–1625.
   PubMed Web of Science ®Google Scholar
• Zimmerman MA, Singh N, Martin PM, Thangaraju M, Ganapathy V, Waller JL, Shi H, Robertson KD, Munn DH, Liu K. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol-Gastrointest Liver Physiol. 2012;302:G1405–15.
   PubMed Web of Science ®Google Scholar
• Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int. 2016;99:110–132.
   PubMed Web of Science ®Google Scholar
• Bozzo L, Puyal J, Chatton J-Y. Lactate modulates the activity of primary cortical neurons through a receptor-mediated pathway. PloS One. 2013;8:e71721.
   PubMedGoogle Scholar
• Ehrlich AM, Pacheco AR, Henrick BM, Taft D, Xu G, Huda MN, Mishchuk D, Goodson ML, Slupsky C, Barile D, et al. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol. 2020;20:357.
   PubMed Web of Science ®Google Scholar
• Meng D, Sommella E, Salviati E, Campiglia P, Ganguli K, Djebali K, Zhu W, Walker WA. Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine. Pediatr Res. 2020;88:209–217.
   PubMed Web of Science ®Google Scholar
• Huang W, Cho KY, Meng D, Walker WA. The impact of indole-3-lactic acid on immature intestinal innate immunity and development: a transcriptomic analysis. Sci Rep. 2021;11:8088.
   PubMed Web of Science ®Google Scholar
• Pyclik M, Srutkova D, Schwarzer M, Górska S. Bifidobacteria cell wall-derived exo-polysaccharides, lipoteichoic acids, peptidoglycans, polar lipids and proteins – their chemical structure and biological attributes. Int J Biol Macromol. 2020;147:333–349.
   PubMed Web of Science ®Google Scholar
• López P, Monteserín DC, Gueimonde M, de Los Reyes-Gavilán CG, Margolles A, Suárez A, Ruas-Madiedo P. Exopolysaccharide-producing Bifidobacterium strains elicit different in vitro responses upon interaction with human cells. Food Res Int. 2012;46:99–107.
   Web of Science ®Google Scholar
• Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, O’ Connell-Motherway M, Shanahan F, Nally K, Dougan G, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci. 2012;109:2108–2113.
   PubMed Web of Science ®Google Scholar
• Yan S, Yang B, Zhao J, Zhao J, Stanton C, Ross RP, Zhang H, Chen W. A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food Funct. 2019;10:1595–1608.
   PubMed Web of Science ®Google Scholar
• Ivanov D, Emonet C, Foata F, Affolter M, Delley M, Fisseha M, Blum-Sperisen S, Kochhar S, Arigoni F. A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases. J Biol Chem. 2006;281:17246–17252.
   PubMed Web of Science ®Google Scholar
• Turroni F, Foroni E, O’ Connell-Motherway M, Bottacini F, Giubellini V, Zomer A, Ferrarini A, Delledonne M, Zhang Z, van Sinderen D, et al. Characterization of the serpin-encoding gene of Bifidobacterium breve 210b. Appl Environ Microbiol. 2010;76:3206–3219.
   PubMed Web of Science ®Google Scholar
• McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, Duboux S, Steinmann M, Delley M, Tangyu M, et al. A commensal Bifidobacterium longum strain prevents gluten-related immunopathology in mice through expression of a serine protease inhibitor. Appl Environ Microbiol. 2017;83:17–e01323.
   Web of Science ®Google Scholar
• Mkaouar H, Mariaule V, Rhimi S, Hernandez J, Kriaa A, Jablaoui A, Akermi N, Maguin E, Lesner A, Korkmaz B, et al. Gut serpinome: emerging evidence in ibd. Int J Mol Sci. 2021;22:6088.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen H, Ding J, Stanton C, Ross RP, Zhao J, Zhang H, Yang B, Chen W. Bifidobacterium longum ameliorates dextran sulfate sodium-induced colitis by producing conjugated linoleic acid, protecting intestinal mechanical barrier, restoring unbalanced gut microbiota, and regulating the toll-like receptor-4/nuclear factor-κb signaling pathway. J Agric Food Chem. 2021;69:14593–14608.
   PubMed Web of Science ®Google Scholar
• Healy DB, Ryan CA, Ross RP, Stanton C, Dempsey EM. Clinical implications of preterm infant gut microbiome development. Nat Microbiol. 2022;7:22–33.
   PubMed Web of Science ®Google Scholar
• Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, O’ Shea CA, Watkins C, Dempsey E, Mattivi F, Tuohy K, et al. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome. 2017;5:4.
   PubMed Web of Science ®Google Scholar
• Meister AL, Doheny KK, Travagli RA. Necrotizing enterocolitis: it’s not all in the gut. Exp Biol Med Maywood NJ. 2020;245:85–95.
   PubMed Web of Science ®Google Scholar
• McMurtry VE, Gupta RW, Tran L, Blanchard EE, Penn D, Taylor CM, Ferris MJ. Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis. Microbiome. 2015;3:11.
   PubMed Web of Science ®Google Scholar
• Warner BB, Deych E, Zhou Y, Hall-Moore C, Weinstock GM, Sodergren E, Shaikh N, Hoffmann JA, Linneman LA, Hamvas A, et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet Lond Engl. 2016;387:1928–1936.
   PubMed Web of Science ®Google Scholar
• Pammi M, Cope J, Tarr PI, Warner BB, Morrow AL, Mai V, Gregory KE, Kroll JS, McMurtry V, Ferris MJ, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome. 2017;5:31.
   PubMed Web of Science ®Google Scholar
• Torrazza RM, Ukhanova M, Wang X, Sharma R, Hudak ML, Neu J, Mai V. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PloS One. 2013;8:e83304.
   PubMed Web of Science ®Google Scholar
• He Y, Du W, Xiao S, Zeng B, She X, Liu D, Du H, Li L, Li F, Ai Q, et al. Colonization of fecal microbiota from patients with neonatal necrotizing enterocolitis exacerbates intestinal injury in germfree mice subjected to necrotizing enterocolitis-induction protocol via alterations in butyrate and regulatory T cells. J Transl Med. 2021;19:510.
   PubMed Web of Science ®Google Scholar
• Cuna A, Yu W, Menden HL, Feng L, Srinivasan P, Chavez-Bueno S, Ahmed I, Umar S, Sampath V. NEC-like intestinal injury is ameliorated by Lactobacillus rhamnosus GG in parallel with SIGIRR and A20 induction in neonatal mice. Pediatr Res. 2020;88:546–555.
   PubMed Web of Science ®Google Scholar
• Murphy K, Ross RP, Ryan CA, Dempsey EM, Stanton C. Probiotics, prebiotics, and synbiotics for the prevention of necrotizing enterocolitis. Front Nutr. 2021;8:667188.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang X, Lv A, Fan S, Zhang J. Saccharomyces boulardii modulates necrotizing enterocolitis in neonatal mice by regulating the sirtuin 1/NF‑κB pathway and the intestinal microbiota. Mol Med Rep. 2020;22:671–680.
   PubMed Web of Science ®Google Scholar
• Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, Morley CJ, Garland SM, ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132:1055–1062.
   PubMed Web of Science ®Google Scholar
• Plummer EL, Bulach DM, Murray GL, Jacobs SE, Tabrizi SN, Garland SM, ProPrems Study Group. Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial. BMC Microbiol. 2018;18:184.
   PubMed Web of Science ®Google Scholar
• Shashidhar A, Suman Rao PN, Nesargi S, Bhat S, Chandrakala BS. Probiotics for promoting feed tolerance in very low birth weight neonates - a randomized controlled trial. Indian Pediatr. 2017;54:363–367.
   PubMed Web of Science ®Google Scholar
• Hoang DM, Levy EI, Vandenplas Y. The impact of Caesarean section on the infant gut microbiome. Acta Paediatr. 2021;110:60–67.
   PubMed Web of Science ®Google Scholar
• Feldkamp ML, Carey JC, Sadler TW. Development of gastroschisis: review of hypotheses, a novel hypothesis, and implications for research. Am J Med Genet A. 2007;143A:639–652.
   PubMed Web of Science ®Google Scholar
• Powell WT, Borghese RA, Kalanetra KM, Mirmiran M, Mills DA, Underwood MA. Probiotic administration in infants with gastroschisis: a pilot randomized placebo-controlled trial. J Pediatr Gastroenterol Nutr. 2016;62:852–857.
   PubMed Web of Science ®Google Scholar
• Harris EL, Minutillo C, Hart S, Warner TM, Ravikumara M, Nathan EA, Dickinson JE. The long term physical consequences of gastroschisis. J Pediatr Surg. 2014;49:1466–1470.
   PubMed Web of Science ®Google Scholar
• Goulet O. Potential role of the intestinal microbiota in programming health and disease. Nutr Rev. 2015;73:32–40.
   PubMed Web of Science ®Google Scholar
• Ugboko HU, Nwinyi OC, Oranusi SU, Oyewale JO. Childhood diarrhoeal diseases in developing countries. Heliyon. 2020;6:e03690.
   PubMed Web of Science ®Google Scholar
• Kim AH, Hogarty MP, Harris VC, Baldridge MT. The complex interactions between rotavirus and the gut microbiota. Front Cell Infect Microbiol. 2020;10:586751.
   PubMed Web of Science ®Google Scholar
• Muñoz JAM, Chenoll E, Casinos B, Bataller E, Ramón D, Genovés S, Montava R, Ribes JM, Buesa J, Fàbrega J, et al. Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections. Appl Environ Microbiol. 2011;77:8775–8783.
   PubMed Web of Science ®Google Scholar
• Escribano J, Ferré N, Gispert-Llaurado M, Luque V, Rubio-Torrents C, Zaragoza-Jordana M, Polanco I, Codoñer FM, Chenoll E, Morera M, et al. Bifidobacterium longum subsp infantis CECT7210-supplemented formula reduces diarrhea in healthy infants: a randomized controlled trial. Pediatr Res. 2018;83:1120–1128.
   PubMed Web of Science ®Google Scholar
• Park MS, Kwon B, Ku S, Ji GE. The efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 probiotic treatment in infants with rotavirus infection. Nutrients. 2017;9:E887.
   PubMed Web of Science ®Google Scholar
• Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R. Irritable bowel syndrome: the clinical approach. Panminerva Med InternetAvailable from 2018;60 [[cited 2022 May 16]]. https://www.minervamedica.it/index2.php?show=R41Y2018N04A0213.
   PubMed Web of Science ®Google Scholar
• Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial. J Clin Gastroenterol. 2017;51:e5–10.
   PubMed Web of Science ®Google Scholar
• Feuerstein JD, Moss AC, Farraye FA. Ulcerative colitis. Mayo Clin Proc. 2019;94:1357–1373.
   PubMed Web of Science ®Google Scholar
• Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009;104:437–443.
   PubMed Web of Science ®Google Scholar
• Wu B, Yang Y, Xu X, Wang W-P. Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants. World J Pediatr WJP. 2016;12:177–182.
   PubMed Web of Science ®Google Scholar
• Angurana SK, Bansal A, Singhi S, Aggarwal R, Jayashree M, Salaria M, Mangat NK. Evaluation of effect of probiotics on cytokine levels in critically ill children with severe sepsis: a double-blind, placebo-controlled trial. Crit Care Med. 2018;46:1656–1664.
   PubMed Web of Science ®Google Scholar
• Guardamagna O, Amaretti A, Puddu PE, Raimondi S, Abello F, Cagliero P, Rossi M. Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children. Nutr Burbank Los Angel Cty Calif. 2014;30:831–836.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li N, Yang J-J, Zhao D-M, Chen B, Zhang G-Q, Chen S, Cao R-F, Yu H, Zhao C-Y, et al. Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder. Pharmacol Res. 2020;157:104784.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Pham-Thi N, Kerihuel J-C, Durand H, Bohbot S. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv Respir Dis. 2010;4:271–278.
   PubMedGoogle Scholar
• Lau A-Y, Yanagisawa N, Hor Y-Y, Lew L-C, Ong J-S, Chuah L-O, Lee Y-Y, Choi S-B, Rashid F, Wahid N, et al. Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. Benef Microbes. 2018;9:61–70.
   PubMed Web of Science ®Google Scholar
• Miraglia Del Giudice M, Indolfi C, Capasso M, Maiello N, Decimo F, Ciprandi G. Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma. Ital J Pediatr. 2017;43:25.
   PubMed Web of Science ®Google Scholar
• Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355–1360.
   PubMed Web of Science ®Google Scholar
• Soh SE, Aw M, Gerez I, Chong YS, Rauff M, Ng YPM, Wong HB, Pai N, Lee BW, Shek L-C. Probiotic supplementation in the first 6 months of life in at risk Asian infants–effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2009;39:571–578.
   PubMed Web of Science ®Google Scholar
• Navarro-López V, Ramírez-Boscá A, Ramón-Vidal D, Ruzafa-Costas B, Genovés-Martínez S, Chenoll-Cuadros E, Carrión-Gutiérrez M, Horga de la Parte J, Prieto-Merino D, Codoñer-Cortés FM. Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2018;154:37–43.
   PubMed Web of Science ®Google Scholar
• MdAk A, Sarker M, Wan D. Immunomodulatory effects of probiotics on cytokine profiles. Biomed Res Int. 2018;2018:1–10.
   Web of Science ®Google Scholar
• Jameson SC. Maintaining the norm: t-cell homeostasis. Nat Rev Immunol. 2002;2:547–556.
   PubMed Web of Science ®Google Scholar
• O’ Neill I, Schofield Z, Hall LJ. Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases. Emerg Top Life Sci. 2017;1:333–349.
   PubMedGoogle Scholar
• Sykes L, MacIntyre DA, Yap XJ, Ponnampalam S, Teoh TG, Bennett PR. Changes in the Th1: th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2. Mediators Inflamm. 2012;2012:416739
   Google Scholar
• Berger A. Science commentary: th1 and Th2 responses: what are they? BMJ. 2000;321:424.
   PubMed Web of Science ®Google Scholar
• Abrahamsson TR, Sandberg Abelius M, Forsberg A, Björkstén B, Jenmalm MC. A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization: th1/Th2-associated chemokine imbalance. Clin Exp Allergy. 2011;41:1729–1739.
   PubMed Web of Science ®Google Scholar
• Pérez N, Iannicelli JC, Girard-Bosch C, González S, Varea A, Disalvo L, Apezteguia M, Pernas J, Vicentin D, Cravero R. Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status. Eur J Nutr. 2010;49:173–179.
   PubMed Web of Science ®Google Scholar
• Youngster I, Kozer E, Lazarovitch Z, Broide E, Goldman M. Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. Arch Dis Child. 2011;96:345–349.
   PubMed Web of Science ®Google Scholar
• WHO. Cardiovascular diseases [Internet]. 2022. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
   Google Scholar
• Cholesterol Treatment Trialists’ Collaboration CTT), Fulcher J, O’ Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet Lond Engl. 2015;385: 1397–1405.
   PubMed Web of Science ®Google Scholar
• Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur J Prev Cardiol. 2014;21:464–474.
   PubMed Web of Science ®Google Scholar
• Wilson DP Is atherosclerosis a pediatric disease? [Internet]. In: Comprehensive Free Endocrinology Book. 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK395576
   Google Scholar
• Pac-Kozuchowska E, Krawiec P, Grywalska E. Selected risk factors for atherosclerosis in children and their parents with positive family history of premature cardiovascular diseases: a prospective study. BMC Pediatr. 2018;18:123.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(5):S213–256.
   PubMedGoogle Scholar
• Martino F, Puddu PE, Pannarale G, Colantoni C, Zanoni C, Martino E, Barillà F. Arterial blood pressure and serum lipids in a population of children and adolescents from Southern Italy: the Calabrian Sierras Community Study (CSCS). Int J Cardiol. 2013;168:1108–1114.
   PubMed Web of Science ®Google Scholar
• Tomaro-Duchesneau C, Jones ML, Shah D, Jain P, Saha S, Prakash S. Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation. Biomed Res Int. 2014;2014:380316.
   PubMed Web of Science ®Google Scholar
• Bordoni A, Amaretti A, Leonardi A, Boschetti E, Danesi F, Matteuzzi D, Roncaglia L, Raimondi S, Rossi M. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria. Appl Microbiol Biotechnol. 2013;97:8273–8281.
   PubMed Web of Science ®Google Scholar
• Yang B, Chen H, Stanton C, Ross RP, Zhang H, Chen YQ, Chen W. Review of the roles of conjugated linoleic acid in health and disease. J Funct Foods. 2015;15:314–325.
   Web of Science ®Google Scholar
• Kwiterovich PO. Recognition and Management of Dyslipidemia in Children and Adolescents. J Clin Endocrinol Metab. 2008;93:4200–4209.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Geurts L, Hoyles L, Iozzo P, Kraneveld AD, La Fata G, Miani M, Patterson E, Pot B, Shortt C, et al. The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cell Mol Life Sci. 2022;79:80.
   PubMed Web of Science ®Google Scholar
• Barrett E, Ross RP, O’ Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012;113:411–417.
   PubMed Web of Science ®Google Scholar
• Cao Y-N, Feng L-J, Wang B-M, Jiang K, Li S, Xu X, Wang W-Q, Zhao J-W, Wang Y-M. Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells. Saudi J Gastroenterol. 2018;24:59.
   PubMed Web of Science ®Google Scholar
• Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–276.
   PubMed Web of Science ®Google Scholar
• Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol. 2020;11:25.
   PubMed Web of Science ®Google Scholar
• Elsabbagh M, Divan G, Koh Y-J, Kim YS, Kauchali S, Marcín C, Montiel-Nava C, Patel V, Paula CS, Wang C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res off J Int Soc Autism Res. 2012;5:160–179.
   PubMed Web of Science ®Google Scholar
• Department of Health. Estimating prevalence of Autism Spectrum Disorders (ASD) in the Irish population: a review of data sources and epidemiological studies [Internet]. 2018. Available from: https://assets.gov.ie/10707/ce1ca48714424c0ba4bb4c0ae2e510b2.pdf
   Google Scholar
• McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014;133:872–883.
   PubMed Web of Science ®Google Scholar
• Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17:687–701.
   PubMed Web of Science ®Google Scholar
• Lambert GW, Eisenhofer G, Cox HS, Horne M, Kalff V, Kelly M, Jennings GL, Esler MD. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. Life Sci. 1991;49:1061–1072.
   PubMed Web of Science ®Google Scholar
• Thomas M, Bomar PA Upper respiratory tract infection [Internet]. In: StatPearls [Internet]. Treasure Island (FL). 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532961/
   Google Scholar
• Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–494.
   PubMed Web of Science ®Google Scholar
• Fitz-Gibbon S, Tomida S, Chiu B-H, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133:2152–2160.
   PubMed Web of Science ®Google Scholar
• Pécastaings S, Roques C, Nocera T, Peraud C, Mengeaud V, Khammari A, Dréno B. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine®. J Eur Acad Dermatol Venereol JEADV. 2018;32 Suppl 2:15–23.
   PubMed Web of Science ®Google Scholar
• NISC Comparative Sequence Program, Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC, Komarow HD, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22: 850–859.
   PubMed Web of Science ®Google Scholar
• Sun Z, Huang S, Zhu P, Yue F, Zhao H, Yang M, Niu Y, Jing G, Su X, Li H, et al. A microbiome-based index for assessing skin health and treatment effects for atopic dermatitis in children. mSystems. 2019;4:19–e00293.
   Web of Science ®Google Scholar
• O’Sullivan JN, Rea MC, Hill C, Ross RP. Protecting the outside: biological tools to manipulate the skin microbiota. FEMS Microbiol Ecol. 2020;96:fiaa085.
   PubMed Web of Science ®Google Scholar
• Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, Panzer AR, LaMere B, Rackaityte E, Lukacs NW, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016;22:1187–1191.
   PubMed Web of Science ®Google Scholar
• Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107:129–134.
   PubMed Web of Science ®Google Scholar
• Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut. 2002;51:51–55.
   PubMed Web of Science ®Google Scholar
• Lee E, Lee S-Y, Kang M-J, Kim K, Won S, Kim B-J, Choi KY, Kim B-S, Cho H-J, Kim Y, et al. Clostridia in the gut and onset of atopic dermatitis via eosinophilic inflammation. Ann Allergy Asthma Immunol off Publ Am Coll Allergy Asthma Immunol. 2016;117:91–92.e1.
   PubMed Web of Science ®Google Scholar
• Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, Stobberingh EE. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007;56:661–667.
   PubMed Web of Science ®Google Scholar
• Song H, Yoo Y, Hwang J, Na Y-C, Kim HS. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol. 2016;137:852–860.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 2003;111:587–591.
   PubMed Web of Science ®Google Scholar
• Fiocchi A, Pawankar R, Cuello-Garcia C, Ahn K, Al-Hammadi S, Agarwal A, Beyer K, Burks W, Canonica GW, Ebisawa M, et al. World allergy organization-McMaster University guidelines for allergic disease prevention (GLAD-P): probiotics. World Allergy Organ J. 2015;8:4.
   PubMed Web of Science ®Google Scholar
• Elias PM. Optimizing emollient therapy for skin barrier repair in atopic dermatitis. Ann Allergy Asthma Immunol off Publ Am Coll Allergy Asthma Immunol. 2022;128:505–511.
   PubMed Web of Science ®Google Scholar
• Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, et al. Major comorbidities of atopic dermatitis: beyond allergic disorders. Am J Clin Dermatol. 2018;19:821–838.
   PubMed Web of Science ®Google Scholar
• Rautava S, Collado MC, Salminen S, Isolauri E. Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology. 2012;102:178–184.
   PubMed Web of Science ®Google Scholar
• Rodríguez JM. The origin of human milk bacteria: is there a bacterial entero-mammary pathway during late pregnancy and lactation? Adv Nutr Bethesda Md. 2014;5:779–784.
   PubMed Web of Science ®Google Scholar
• Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Björkstén B. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49:349–354.
   PubMed Web of Science ®Google Scholar
• Simpson MR, Avershina E, Storrø O, Johnsen R, Rudi K, Øien T. Breastfeeding-associated microbiota in human milk following supplementation with Lactobacillus rhamnosus GG, Lactobacillus acidophilus La-5, and Bifidobacterium animalis ssp. lactis Bb-12. J Dairy Sci. 2018;101:889–899.
   PubMed Web of Science ®Google Scholar
• Kordy K, Gaufin T, Mwangi M, Li F, Cerini C, Lee DJ, Adisetiyo H, Woodward C, Pannaraj PS, Tobin NH, et al. Contributions to human breast milk microbiome and enteromammary transfer of Bifidobacterium breve. PloS One. 2020;15:e0219633.
   PubMed Web of Science ®Google Scholar
• Salli K, Hirvonen J, Siitonen J, Ahonen I, Anglenius H, Maukonen J. Selective utilization of the human milk oligosaccharides 2’-fucosyllactose, 3-fucosyllactose, and difucosyllactose by various probiotic and pathogenic bacteria. J Agric Food Chem. 2021;69:170–182.
   PubMed Web of Science ®Google Scholar
• Lynch WD, Hsu R. Ulcerative colitis [Internet. StatPearls. Treasure Island (FL): StatPearls Publishing;2022. [cited 2022 May 16]. Available from. http://www.ncbi.nlm.nih.gov/books/NBK459282/
   Google Scholar
• Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O’ Neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54:242–249.
   PubMed Web of Science ®Google Scholar
• Steed H, Macfarlane GT, Blackett KL, Bahrami B, Reynolds N, Walsh SV, Cummings JH, Macfarlane S. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn’s disease. Aliment Pharmacol Ther. 2010;32:872–883.
   PubMed Web of Science ®Google Scholar
• Tamaki H, Nakase H, Inoue S, Kawanami C, Itani T, Ohana M, Kusaka T, Uose S, Hisatsune H, Tojo M, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: a randomized, double-blinded, placebo-controlled multicenter trial. Dig Endosc off J Jpn Gastroenterol Endosc Soc. 2016;28:67–74.
   Google Scholar
• Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, Gigliobianco A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit Int Med J Exp Clin Res. 2004;10:I126–131.
   Google Scholar
• Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, Forti G, Morini S, Hassan C, Pistoia MA, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2010;105:2218–2227.
   PubMed Web of Science ®Google Scholar
• Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, Tandon RK. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol off Clin Pract J Am Gastroenterol Assoc. 2009;7:1202–9, 1209.e1.
   PubMed Web of Science ®Google Scholar
• Fedorak RN, Feagan BG, Hotte N, Leddin D, Dieleman LA, Petrunia DM, Enns R, Bitton A, Chiba N, Paré P, et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s disease. Clin Gastroenterol Hepatol off Clin Pract J Am Gastroenterol Assoc. 2015;13:928–935.e2.
   PubMed Web of Science ®Google Scholar
• Ki Cha B, Mun Jung S, Hwan Choi C, Song I-D, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung W-S, et al. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol. 2012;46:220–227.
   PubMed Web of Science ®Google Scholar
• Bonfrate L, Di Palo DM, Celano G, Albert A, Vitellio P, De Angelis M, Gobbetti M, Portincasa P. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients. Eur J Clin Invest [Internet]. [cited 2022 May 16]; 2020; 50. https://onlinelibrary.wiley.com/doi/10.1111/eci.13201. Available from
   PubMed Web of Science ®Google Scholar
• Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B. The effectiveness of synbiotic preparation containing Lactobacillus and Bifidobacterium probiotic strains and short chain fructooligosaccharides in patients with diarrhea predominant irritable bowel syndrome-a randomized double-blind, placebo-controlled study. Nutrients. 2020;12:E1999.
   PubMed Web of Science ®Google Scholar
• Lewis ED, Antony JM, Crowley DC, Piano A, Bhardwaj R, Tompkins TA, Evans M. Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in alleviating symptoms of irritable bowel syndrome (IBS): a randomized, placebo-controlled study. Nutrients. 2020;12:E1159.
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’ Mahony L, Kiely B, Shanahan F, Quigley EMM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581–1590.
   PubMed Web of Science ®Google Scholar
• O’ Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O’ Sullivan GC, Kiely B, Collins JK, Shanahan F, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541–551.
   PubMed Web of Science ®Google Scholar
• Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr Edinb Scotl. 2014;33:761–767.
   PubMed Web of Science ®Google Scholar
• Martoni CJ, Evans M, Chow CE, Chan LS, Leyer G. Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: a randomized controlled trial. J Dig Dis. 2019;20:435–446.
   PubMed Web of Science ®Google Scholar
• Vitellio P, Celano G, Bonfrate L, Gobbetti M, Portincasa P, De Angelis M. Effects of Bifidobacterium longum and Lactobacillus rhamnosus on gut microbiota in patients with lactose intolerance and persisting functional gastrointestinal symptoms: a randomised, double-blind, cross-over study. Nutrients. 2019;11:E886.
   PubMed Web of Science ®Google Scholar
• Diop L, Guillou S, Durand H. Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial. Nutr Res N Y N. 2008;28:1–5.
   PubMed Web of Science ®Google Scholar
• Hütt P, Andreson H, Kullisaar T, Vihalemm T, Unt E, Kals J, Kampus P, Zilmer M, Mikelsaar M. Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori. Lett Appl Microbiol. 2009;48:797–800.
   PubMed Web of Science ®Google Scholar
• Groeger D, O’ Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EMM. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013;4:325–339.
   PubMed Web of Science ®Google Scholar
• Wang I-K, Y-Y W, Yang Y-F, Ting I-W, Lin C-C, Yen T-H, Chen J-H, Wang C-H, Huang C-C, Lin H-C. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes. 2015;6:423–430.
   PubMed Web of Science ®Google Scholar
• Haghighat N, Mohammadshahi M, Shayanpour S, Haghighizadeh MH. Effects of synbiotics and probiotics supplementation on serum levels of endotoxin, heat shock protein 70 antibodies and inflammatory markers in hemodialysis patients: a randomized double-blinded controlled trial. Probiotics Antimicrob Proteins. 2020;12:144–151.
   PubMed Web of Science ®Google Scholar
• Andrade S, Borges N. Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J Dairy Res. 2009;76:469–474.
   PubMed Web of Science ®Google Scholar
• Asemi Z, Zare Z, Shakeri H, Sabihi S, Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013;63:1–9.
   PubMed Web of Science ®Google Scholar
• Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson J-F, Rougeot C, Pichelin M, Cazaubiel M, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105:755–764.
   PubMed Web of Science ®Google Scholar
• Romijn AR, Rucklidge JJ, Kuijer RG, Frampton C. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust N Z J Psychiatry. 2017;51:810–821.
   PubMed Web of Science ®Google Scholar
• Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 2019;38:522–528.
   PubMed Web of Science ®Google Scholar
• Kazemi A, Noorbala AA, Djafarian K. Effect of probiotic and prebiotic versus placebo on appetite in patients with major depressive disorder: post hoc analysis of a randomised clinical trial. J Hum Nutr Diet. 2020;33:56–65.
   PubMed Web of Science ®Google Scholar
• Marotta A, Sarno E, Del Casale A, Pane M, Mogna L, Amoruso A, Felis GE, Fiorio M. Effects of probiotics on cognitive reactivity, mood, and sleep quality. Front Psychiatry. 2019;10:164.
   PubMed Web of Science ®Google Scholar
• Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin F-P, Cominetti O, Welsh C, Rieder A, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017;153:448–459.e8.
   PubMed Web of Science ®Google Scholar
• Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, Tajabadi-Ebrahimi M, Asemi Z. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial. Clin Nutr Edinb Scotl. 2019;38:2569–2575.
   PubMed Web of Science ®Google Scholar
• Xiao J-Z, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Togashi H, Enomoto K, et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2006;36:1425–1435.
   PubMed Web of Science ®Google Scholar
• Odamaki T, Xiao J-Z, Iwabuchi N, Sakamoto M, Takahashi N, Kondo S, Miyaji K, Iwatsuki K, Togashi H, Enomoto T, et al. Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season. J Med Microbiol. 2007;56:1301–1308.
   PubMed Web of Science ®Google Scholar
• Xiao J, Kondo S, Yanagisawa N, Miyaji K, Enomoto K, Sakoda T, Iwatsuki K, Enomoto T. Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Int off J Jpn Soc Allergol. 2007;56:67–75.
   PubMedGoogle Scholar
• Dennis-Wall JC, Culpepper T, Nieves C, Rowe CC, Burns AM, Rusch CT, Federico A, Ukhanova M, Waugh S, Mai V, et al. Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial. Am J Clin Nutr. 2017;105:758–767.
   PubMed Web of Science ®Google Scholar
• Kang M-G, Han S-W, Kang H-R, Hong S-J, Kim D-H, Choi J-H. Probiotic NVP-1703 alleviates allergic rhinitis by inducing IL-10 Expression: a four-week clinical trial. Nutrients. 2020;12:E1427.
   PubMed Web of Science ®Google Scholar
• de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr Edinb Scotl. 2005;24:481–491.
   PubMed Web of Science ®Google Scholar
• Guéniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V, Breton L, Castiel-Higounenc I. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp Dermatol. 2010;19:e1–8.
   PubMed Web of Science ®Google Scholar
• Yeh H-W, Chien W-C, Chung C-H, J-M H, Tzeng N-S. Risk of psychiatric disorders in irritable bowel syndrome-A nationwide, population-based, cohort study. Int J Clin Pract. 2018;72:e13212.
   PubMed Web of Science ®Google Scholar
• Patel SM, Stason WB, Legedza A, Ock SM, Kaptchuk TJ, Conboy L, Canenguez K, Park JK, Kelly E, Jacobson E, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis1. Neurogastroenterol Motil. 2005;17:332–340.
   PubMed Web of Science ®Google Scholar
• Visich KL, Yeo TP. The prophylactic use of probiotics in the prevention of radiation therapy-induced diarrhea. Clin J Oncol Nurs. 2010;14:467–473.
   PubMed Web of Science ®Google Scholar
• Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582–1591. quiz 1581, 1592.
   PubMed Web of Science ®Google Scholar
• Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65:57–62.
   PubMed Web of Science ®Google Scholar
• Jiang T, Mustapha A, Savaiano DA. Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum. J Dairy Sci. 1996;79:750–757.
   PubMed Web of Science ®Google Scholar
• Labanski A, Langhorst J, Engler H, Elsenbruch S. Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: a transdisciplinary challenge. Psychoneuroendocrinology. 2020;111:104501.
   PubMed Web of Science ®Google Scholar
• Jain U, Saxena K, Chauhan N. Helicobacter pylori induced reactive oxygen Species: a new and developing platform for detection. Helicobacter [Internet]. [cited 2022 Jun 21]; 2021; 26. https://onlinelibrary.wiley.com/doi/10.1111/hel.12796. Available from
   PubMed Web of Science ®Google Scholar
• Qadri Q, Rasool R, Gulzar GM, Naqash S, Shah ZA. H. pylori infection, inflammation and gastric cancer. J Gastrointest Cancer. 2014;45:126–132.
   PubMedGoogle Scholar
• Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol. 2006;100:1324–1332.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426–431.
   PubMed Web of Science ®Google Scholar
• Hauser AB, Stinghen AEM, Gonçalves SM, Bucharles S, Pecoits-Filho R. A gut feeling on endotoxemia: causes and consequences in chronic kidney disease. Nephron Clin Pract. 2011;118:c165–172. discussion c172.
   PubMedGoogle Scholar
• Sun PP, Perianayagam MC, Jaber BL. Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism. Kidney Int Suppl. 2009;76:S20–25.
   PubMedGoogle Scholar
• Wang I-K, Lai H-C, C-J Y, Liang C-C, Chang C-T, Kuo H-L, Yang Y-F, Lin C-C, Lin H-H, Liu Y-L, et al. Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients. Appl Environ Microbiol. 2012;78:1107–1112.
   PubMed Web of Science ®Google Scholar
• Lebherz-Eichinger D, Krenn CG, Roth GA. Keratin 18 and heat-shock protein in chronic kidney disease. Adv Clin Chem. 2013;62:123–149.
   PubMed Web of Science ®Google Scholar
• Grill J, Schneider F, Crociani J, Ballongue J. Purification and characterization of conjugated bile salt hydrolase from Bifidobacterium longum bb536. Appl Environ Microbiol. 1995;61:2577–2582.
   PubMed Web of Science ®Google Scholar
• Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11:45–63.
   PubMedGoogle Scholar
• WHO. Depression and other common mental disorders: global health estimates. Geneva: World Health Organization; 2017.
   Google Scholar
• Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391:1357–1366.
   PubMed Web of Science ®Google Scholar
• Oxenkrug G. Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Curr Drug Targets. 2013;14:514–521.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Ajdacic V, Rössler W, Steinhausen H-C, Angst J. Prevalence of seasonal depression in a prospective cohort study. Eur Arch Psychiatry Clin Neurosci. 2019;269:833–839.
   PubMed Web of Science ®Google Scholar
• Shiha MG, Aziz I. Review article: physical and psychological comorbidities associated with irritable bowel syndrome. Aliment Pharmacol Ther [Internet]. [cited 2022 Jun 27]; 2021; 54. https://onlinelibrary.wiley.com/doi/10.1111/apt.16589. Available from
   PubMed Web of Science ®Google Scholar
• Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23:1132–1139.
   PubMed Web of Science ®Google Scholar
• Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139:2102–2112.e1.
   PubMed Web of Science ®Google Scholar
• Maqsood R, Stone TW. The gut-brain axis, BDNF, NMDA and CNS disorders. Neurochem Res. 2016;41:2819–2835.
   PubMed Web of Science ®Google Scholar
• Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci. 2011;108:3047–3052.
   PubMed Web of Science ®Google Scholar
• WHO. Dementia [Internet]. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia
   Google Scholar
• Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21:306–318.
   PubMed Web of Science ®Google Scholar
• Guo L, Xu J, Du Y, Wu W, Nie W, Zhang D, Luo Y, Lu H, Lei M, Xiao S, et al. Effects of gut microbiota and probiotics on Alzheimer’s disease. Transl Neurosci. 2021;12:573–580.
   PubMed Web of Science ®Google Scholar
• Jiang C, Li G, Huang P, Liu Z, Zhao B. The gut microbiota and alzheimer’s disease. J Alzheimers Dis. 2017;58:1–15.
   PubMed Web of Science ®Google Scholar
• Gubandru M, Margina D, Tsitsimpikou C, Goutzourelas N, Tsarouhas K, Ilie M, Tsatsakis AM, Kouretas D. Alzheimer’s disease treated patients showed different patterns for oxidative stress and inflammation markers. Food Chem Toxicol. 2013;61:209–214.
   PubMed Web of Science ®Google Scholar
• Aaseth J, Skalny AV, Roos PM, Alexander J, Aschner M, Tinkov AA. Copper, iron, selenium and lipo-glycemic dysmetabolism in Alzheimer’s disease. Int J Mol Sci. 2021;22:9461.
   PubMed Web of Science ®Google Scholar
• Wei Z, Koya J, Reznik SE. Insulin resistance exacerbates Alzheimer disease via multiple mechanisms. Front Neurosci. 2021;15:687157.
   PubMed Web of Science ®Google Scholar
• Dimache AM, Șalaru DL, Sascău R, Stătescu C. The role of high triglycerides level in predicting cognitive impairment: a review of current evidence. Nutrients. 2021;13:2118.
   PubMed Web of Science ®Google Scholar
• Pereira ME, Souza JV, Galiciolli MEA, Sare F, Vieira GS, Kruk IL, Oliveira CS. Effects of Selenium supplementation in patients with mild cognitive impairment or alzheimer’s disease: a systematic review and meta-analysis. Nutrients. 2022;14:3205.
   PubMed Web of Science ®Google Scholar
• Enomoto T. Reevaluation of hygiene theory. Arerugi Allergy. 2004;53:465–468.
   PubMedGoogle Scholar
• Renert-Yuval Y, Thyssen JP, Bissonnette R, Bieber T, Kabashima K, Hijnen D, Guttman-Yassky E. Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council. J Allergy Clin Immunol. 2021;147:1174–1190.e1.
   PubMed Web of Science ®Google Scholar
• Salazar N, González S, Nogacka AM, Rios-Covián D, Arboleya S, Gueimonde M, de L RGC. Microbiome: effects of ageing and diet. Curr Issues Mol Biol. 2020;36:33–62.
   PubMed Web of Science ®Google Scholar
• Biagi E, Rampelli S, Turroni S, Quercia S, Candela M, Brigidi P. The gut microbiota of centenarians: signatures of longevity in the gut microbiota profile. Mech Ageing Dev. 2017;165:180–184.
   PubMed Web of Science ®Google Scholar
• Salazar N, López P, Valdés L, Margolles A, Suárez A, Patterson ÁM, Cuervo A, de Los RGC, Ruas-Madiedo P, Gonzalez S, et al. Microbial targets for the development of functional foods accordingly with nutritional and immune parameters altered in the elderly. J Am Coll Nutr. 2013;32:399–406.
   PubMed Web of Science ®Google Scholar
• Salazar N, Arboleya S, Valdã©s L, Stanton C, Ross P, Ruiz L, Gueimonde M, de Los Reyes-Gavilã¡n Cg. The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet [Internet] Available from 2014;5 [[cited 2022 May 16]]. http://journal.frontiersin.org/article/10.3389/fgene.2014.00406/abstract.
   PubMed Web of Science ®Google Scholar
• Pitkala KH, Strandberg TE, Finne Soveri UH, Ouwehand AC, Poussa T, Salminen S. Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. J Nutr Health Aging. 2007;11:305–311.
   PubMed Web of Science ®Google Scholar
• Kondo J. Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding. World J Gastroenterol. 2013;19:2162.
   PubMed Web of Science ®Google Scholar
• Ouwehand AC, Bergsma N, Parhiala R, Lahtinen S, Gueimonde M, Finne-Soveri H, Strandberg T, Pitkälä K, Salminen S. Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol. 2008;53:18–25.
   PubMedGoogle Scholar
• Akatsu H, Iwabuchi N, Xiao J, Matsuyama Z, Kurihara R, Okuda K, Yamamoto T, Maruyama M. Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. J Parenter Enter Nutr. 2013;37:631–640.
   PubMed Web of Science ®Google Scholar
• Macfarlane S, Cleary S, Bahrami B, Reynolds N, Macfarlane GT. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther. 2013;38:804–816.
   PubMed Web of Science ®Google Scholar
• Spaiser SJ, Culpepper T, Nieves C, Ukhanova M, Mai V, Percival SS, Christman MC, Langkamp-Henken B. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 ingestion induces a less inflammatory cytokine profile and a potentially beneficial shift in gut microbiota in older adults: a randomized, double-blind, placebo-controlled, crossover study. J Am Coll Nutr. 2015;34:459–469.
   PubMed Web of Science ®Google Scholar
• Finamore A, Roselli M, Donini L, Brasili DE, Rami R, Carnevali P, Mistura L, Pinto A, Giusti A, Mengheri E. Supplementation with Bifidobacterium longum Bar33 and Lactobacillus helveticus Bar13 mixture improves immunity in elderly humans (over 75 years) and aged mice. Nutr Burbank Los Angel Cty Calif. 2019;63–64:184–192.
   PubMed Web of Science ®Google Scholar
• Inoue T, Kobayashi Y, Mori N, Sakagawa M, Xiao J-Z, Moritani T, Sakane N, Nagai N. Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects. Benef Microbes. 2018;9:843–853.
   PubMed Web of Science ®Google Scholar
• Kim C-S, Cha L, Sim M, Jung S, Chun WY, Baik HW, Shin D-M. Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: a randomized, double-blind, placebo-controlled, multicenter trial. J Gerontol Ser A. 2021;76:32–40.
   PubMed Web of Science ®Google Scholar
• Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol OncolJ Hematol Oncol. 2020;13:151.
   PubMed Web of Science ®Google Scholar
• Walford RL. The immunologic theory of aging. The Gerontologist. 1964;4:195–197.
   PubMedGoogle Scholar
• Brüünsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am. 2003;23:15–39.
   PubMed Web of Science ®Google Scholar
• Miles EA, Rees D, Banerjee T, Cazzola R, Lewis S, Wood R, Oates R, Tallant A, Cestaro B, Yaqoob P, et al. Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis. 2008;196:298–305.
   PubMed Web of Science ®Google Scholar
• Takeda K, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-Cell activity. J Nutr. 2007;137:791S–793S.
   PubMed Web of Science ®Google Scholar
• Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001;74:833–839.
   PubMed Web of Science ®Google Scholar
• Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12 ® and Lactobacillus paracasei ssp. paracasei, L. casei 431 ® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2012;107:876–884.
   PubMed Web of Science ®Google Scholar
• Cai L, Chan JSY, Yan JH, Peng K. Brain plasticity and motor practice in cognitive aging. Front Aging Neurosci [Internet] Available from 2014;6 [[cited 2022 Sep 6]]. http://journal.frontiersin.org/article/10.3389/fnagi.2014.00031/abstract.
   PubMed Web of Science ®Google Scholar
• Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-benarous F, Hampel H, Kochan NA, et al. Subjective cognitive decline and rates of incident Alzheimer’s disease and non–alzheimer’s disease dementia. Alzheimers Dement. 2019;15:465–476.
   PubMed Web of Science ®Google Scholar
• for Cohort Studies of Memory in an International Consortium, Cosmic) RS, Pabst A, Riedel-Heller SG, Jessen F, Turana Y, Handajani YS, Brayne C, Matthews FE, Stephan BCM, et al. Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study. Alzheimers Res Ther. 2020;12: 167.
   PubMed Web of Science ®Google Scholar
• Branco ACCC, Yoshikawa FSY, Pietrobon AJ, Sato MN. Role of histamine in modulating the immune response and inflammation. Mediators Inflamm. 2018;2018:1–10.
   Web of Science ®Google Scholar
• NCD Alliance. The financial burden of NCDs [Internet]. 2017. Available from: https://ncdalliance.org/why-ncds/the-financial-burden-of-ncds#:~:text=In%20total%20the%20five%20leading,US%24%202%20trillion%20per%20year
   Google Scholar
• WHO. Noncommunicable diseases [Internet]. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
   Google Scholar